Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App




Single Assay Enables Simultaneous Newborn Screening for Three Severe Genetic Disorders

By LabMedica International staff writers
Posted on 30 Sep 2026

Newborn screening aims to identify serious genetic disorders within the first days of life, when swift intervention can help prevent irreversible harm. More...

Spinal muscular atrophy, severe combined immunodeficiency, and sickle cell disease can lead to rapid disability, severe infections, or early mortality if not recognized promptly, highlighting the need for consolidated assays that fit routine screening workflows. Addressing this need, a newly launched CE-marked assay now screens for all three conditions simultaneously.

TIB MOLBIOL, a Roche Diagnostics subsidiary, has introduced the LightMix Newborn TREC/SMN1/HBB kit, an in vitro diagnostic assay for newborn screening in countries that accept the CE mark. The kit simultaneously screens for spinal muscular atrophy (SMA), severe combined immunodeficiency (SCID), and sickle cell disease (SCD) in a single assay designed for routine laboratory use. It is intended for private and academic hospital laboratories seeking standardized implementation without extensive in-house method development.

The assay runs on established LightCycler systems, enabling laboratories already using the platform to incorporate the new screen with minimal disruption. It is described as a first‑tier test that can immediately trigger confirmatory diagnostics and treatment planning when results indicate risk. The kit expands Roche’s early diagnostics portfolio while emphasizing integration into existing laboratory workflows.

Early detection is highlighted as central to clinical benefit. Identifying SMA at birth allows clinicians to initiate targeted therapies that may prevent severe nerve damage, permanent disability, and missed developmental milestones. For SCD, prompt recognition supports interventions such as preventive penicillin and specialized immunizations that can reduce infant mortality. In SCID, diagnosing the condition before infections occur enables potentially lifesaving measures, including bone marrow transplantation.

“When a baby is born with a condition like SMA or SCID, every single day counts. Catching these diseases before symptoms appear isn't just about early diagnosis; it's the difference between a child thriving or facing severe, lifelong disability. By expanding our compliant newborn screening tools across Europe, we are helping laboratories transition to high-precision solutions that ensure no critical diagnosis is delayed,” said Marcus Droege, CEO of TIB MOLBIOL.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Automated Immunoassay Analyzer
SuperFlex™
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image

Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil

Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.